Skip to records

Therapeutics

229Aging Biotech
100 of 229 records

Hydralazine

Source date not recordedAnalyse record ↗
Modality
small molecule
Kind
rate-of-aging
Tested by ITP
yes
ITP year first tested
2020
ITP median % ↑ (♂, best cohort)
5.00
ITP median % ↑ (♀, best cohort)
-1.70
ITP P90 % ↑ (♂, best cohort)
0.60
ITP P90 % ↑ (♀, best cohort)
0.50
ITP sex effect
neither
ITP dose (ppm)
30 ppm
ITP age at start (mo)
6 mo; 16 mo
ITP replicated
no
ITP result status
Published (full stats)

ITP cohort detail (2)

YearCohortDose♂ med♀ med♂ P90♀ P90Citation
2020C202030 ppm5%-1.7%0.6%-6.1%↗ paper
2020C202030 ppm4.4%-1.9%-2.7%0.5%↗ paper